Or Filter by:

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

06-NOV-2019

Elanco Animal Health Reports Third Quarter Results

Post by: Colleen Parr Dekker

  • Earnings per share (EPS) was $0.03 (reported), or $0.30 (adjusted) for the third quarter 2019, including a benefit of $0.02 from a tax item
  • Gross margin improved to 53.3 percent of revenue (reported and adjusted), an improvement of 190 basis points (reported) and 210 basis points (adjusted) for the third quarter 2019
  • Total Revenue in the third quarter of 2019 increased 1 percent to $771.3 million; Total and Core Revenue grew 2 percent and 4 percent, respectively, at constant currency rates
  • Announced agreement to acquire the animal health business of Bayer AG
  • Updates expected 2019 revenue guidance to $3.070 billion - $3.085 billion and EPS guidance to $0.10 - $0.18 (reported), or $1.04 - $1.08 (adjusted)

Media Contact:
Colleen Parr Dekker
(317) 989-7011
colleen_parr_dekker@elanco.com

Investors Contact:
Jim Greffet
(317) 383-9935
greffet_james_f@elanco.com

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

About Elanco

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.